Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

VA Health Systems Research

Go to the VA ORD website
Go to the QUERI website

HSR Citation Abstract

Search | Search by Center | Search by Source | Keywords in Title

Substance use and use disorders among Veterans on long-term opioid therapy.

Ngo, Keyhani, Leonard, Hoggatt. Substance use and use disorders among Veterans on long-term opioid therapy. Drug and Alcohol Dependence Reports. 2025 Sep 1; 16:100347, DOI: 10.1016/j.dadr.2025.100347.

Dimensions for VA is a web-based tool available to VA staff that enables detailed searches of published research and research projects.

If you have VA-Intranet access, click here for more information vaww.hsrd.research.va.gov/dimensions/

VA staff not currently on the VA network can access Dimensions by registering for an account using their VA email address.
   Search Dimensions for VA for this citation
* Don't have VA-internal network access or a VA email address? Try searching the free-to-the-public version of Dimensions



Abstract:

BACKGROUND: Few studies have reported on the prevalence and health risks associated with substance use and substance use disorder (SU/SUD) in Veterans who use long-term opioid therapy (LTOT). We leveraged health record data to estimate SU/SUD prevalence and its association with mortality among Veterans on LTOT. METHODS: We conducted a secondary analysis of cohort data for Veterans on LTOT within Veterans Health Administration outpatient settings (2014-2019). SU/SUD was defined as a positive screen for risky alcohol use; a positive urine drug screen for cannabis, benzodiazepines, or stimulants; or a documented SUD diagnosis. We fit Cox models for all-cause mortality, fatal overdose, and traumatic deaths, comparing Veterans on LTOT with SU/SUD vs. LTOT-only. RESULTS: One in four (25.0 %) Veterans on LTOT have risky alcohol use, tested positive for other substances, or had a diagnosed SUD. Alcohol was the most common SU/SUD (9.8 %), followed by sedative (8.1 %), cannabis (6.6 %), and stimulant (0.6 %). Relative to Veterans on LTOT only, mortality rates were higher for Veterans on LTOT with cannabis (HR = 1.16, 95 % CI = 1.03, 1.30), sedative (HR = 1.29, 95 % CI = 1.10, 1.52), or stimulant SU/SUD (HR = 1.54, 95 % CI = 1.17, 2.02). Fatal overdose rates were higher for LTOT with alcohol (HR = 1.43, 95 % CI = 1.10, 1.86), sedatives (HR = 1.40, 95 % CI = 1.04, 1.91), or stimulant SU/SUD (HR = 3.29, 95 % CI = 1.60, 6.77). LTOT with sedative SU/SUD was associated with traumatic death rates (HR = 1.30, 95 % CI = 1.05, 1.61). CONCLUSION: Substance co-use is common among Veterans on LTOT and is associated with elevated mortality and overdose risks. Comprehensive screening and targeted interventions may be needed.





Questions about the HSR website? Email the Web Team

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.